Anti-TNFRSF5/CD40 Antibody (Lucatumumab)
Catalog No.
F1060
Anti-TNFRSF5/CD40 Antibody (Lucatumumab)
Featured Products
Lucatumumab (HCD122) is a fully human anti-CD40 antagonist monoclonal antibody that blocks CD40/CD40L-mediated signaling pathways. Lucatumumab can effectively mediate antibody-dependent cell-mediated cytotoxicity (ADCC) and tumor cell clearance, and can be used in the study of refractory lymphoma, chronic lymphocytic leukemia (CLL) and multiple myeloma.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
903512-50-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
HCD122, CHIR-12.12, 5H7
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P25942
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFRSF5 / CD40
Please avoid freeze-thaw cycles.